Stock 4671 FALCO HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings FALCO HOLDINGS Co., Ltd.

Equities

4671

JP3802650006

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-31 am EDT 		5-day change 1st Jan Change
2,312 JPY +1.36% Intraday chart for FALCO HOLDINGS Co., Ltd. +0.57% +10.73%
Jan. 30 Tranche Update on FALCO HOLDINGS Co., Ltd.'s Equity Buyback Plan announced on August 10, 2023. CI
Jan. 29 FALCO HOLDINGS Co., Ltd.'s Equity Buyback announced on August 10, 2023, has closed with 587,500 shares, representing 5.29% for ¥1,199.88 million. CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • The company shows low valuation levels, with an enterprise value at 0.35 times its sales.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
FALCO HOLDINGS CO., LTD. Stock FALCO HOLDINGS Co., Ltd.
+10.73% 157M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-24.16% 7.76B
B+
RADNET, INC. Stock RadNet, Inc.
+68.65% 4.33B
C+
SYNLAB AG Stock SYNLAB AG
-2.98% 2.64B -
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+2.72% 2.63B
B-
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-46.17% 2.16B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-15.27% 1.75B
C-
FLEURY S.A. Stock Fleury S.A.
-22.12% 1.46B
A-
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+13.62% 1.17B
B+
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-43.81% 1.14B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
-
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4671 Stock
  4. Ratings FALCO HOLDINGS Co., Ltd.